Healthcare provider profile · identity verified

Garry Alvarez, ANP-BC

Nurse Practitioner · BROOKLYN, NY · NPI 1396379566

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	416	137
Amlodipine Besylate	Amlodipine Besylate	293	109
Furosemide	Furosemide	226	85
Gabapentin	Gabapentin	208	81
Eliquis	Apixaban	205	58
Metoprolol Succinate	Metoprolol Succinate	175	71
Latanoprost	Latanoprost	168	46
Metformin Hcl	Metformin Hcl	145	50
Losartan Potassium	Losartan Potassium	137	48
Tamsulosin Hcl	Tamsulosin Hcl	137	37
Albuterol Sulfate Hfa	Albuterol Sulfate	136	41
Pantoprazole Sodium	Pantoprazole Sodium	132	44
Nifedipine Er	Nifedipine	131	43
Doxepin Hcl	Doxepin Hcl	130	18
Nystatin	Nystatin	124	36
Metoprolol Tartrate	Metoprolol Tartrate	114	29
Diclofenac Sodium Er	Diclofenac Sodium	104	12
Hydralazine Hcl	Hydralazine Hcl	104	37
Levothyroxine Sodium	Levothyroxine Sodium	99	35
Simvastatin	Simvastatin	98	31
Donepezil Hcl	Donepezil Hcl	93	26
Quetiapine Fumarate	Quetiapine Fumarate	92	23
Trazodone Hcl	Trazodone Hcl	89	34
Famotidine	Famotidine	88	31
Fluticasone Propionate	Fluticasone Propionate	86	24
Januvia	Sitagliptin Phosphate	84	27
Mupirocin	Mupirocin	82	42
Levetiracetam	Levetiracetam	81	30
Ozempic	Semaglutide	72	12
Clopidogrel	Clopidogrel Bisulfate	66	24
Baclofen	Baclofen	64	19
Hydrochlorothiazide	Hydrochlorothiazide	63	26
Rosuvastatin Calcium	Rosuvastatin Calcium	62	24
Alcohol Prep Pads	Alcohol Antiseptic Pads	61	19
Entresto	Sacubitril/Valsartan	60	13
Diclofenac Sodium	Diclofenac Sodium	59	26
Lactulose	Lactulose	59	27
Omeprazole	Omeprazole	58	18
Mirtazapine	Mirtazapine	56	15
Glipizide Er	Glipizide	54	19
Combigan	Brimonidine Tartrate/Timolol	53	16
Ciprofloxacin Hcl	Ciprofloxacin Hcl	51	46
Duloxetine Hcl	Duloxetine Hcl	51	23
Finasteride	Finasteride	51	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	50	15
Lisinopril	Lisinopril	47	18
Spironolactone	Spironolactone	47	11
Silver Sulfadiazine	Silver Sulfadiazine	45	22
Carvedilol	Carvedilol	44	18
Labetalol Hcl	Labetalol Hcl	43	20
Montelukast Sodium	Montelukast Sodium	43	14
Jardiance	Empagliflozin	41	11
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	40	15
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	39	18
Brimonidine Tartrate	Brimonidine Tartrate	39	12
Ammonium Lactate	Ammonium Lactate	38	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	20
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	34	11
Glipizide	Glipizide	34	12
Enalapril Maleate	Enalapril Maleate	33	16
Linzess	Linaclotide	33	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	suppressed
Single Use Swab	Alcohol Antiseptic Pads	33	19
Memantine Hcl	Memantine Hcl	32	20
Novolog Flexpen	Insulin Aspart	32	suppressed
Hydrocortisone	Hydrocortisone	31	15
Allopurinol	Allopurinol	30	11
Triamcinolone Acetonide	Triamcinolone Acetonide	29	suppressed
Valsartan	Valsartan	29	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	28	11
Betamethasone Dipropionate	Betamethasone Dipropionate	27	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	27	suppressed
Xarelto	Rivaroxaban	27	suppressed
Amiodarone Hcl	Amiodarone Hcl	26	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	22
Naproxen Sodium	Naproxen Sodium	26	12
Ssd	Silver Sulfadiazine	26	12
Farxiga	Dapagliflozin Propanediol	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Metformin Hcl Er	Metformin Hcl	24	suppressed
Ketoconazole	Ketoconazole	23	suppressed
Brinzolamide	Brinzolamide	22	suppressed
Tradjenta	Linagliptin	22	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	21	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	19	suppressed
Meloxicam	Meloxicam	19	suppressed
Citalopram Hbr	Citalopram Hydrobromide	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Nystop	Nystatin	18	suppressed
Torsemide	Torsemide	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Cephalexin	Cephalexin	17	suppressed
Repaglinide	Repaglinide	17	suppressed
Rexulti	Brexpiprazole	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Timolol Maleate	Timolol Maleate	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Azithromycin	Azithromycin	15	14
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Divalproex Sodium	Divalproex Sodium	15	suppressed
Haloperidol Decanoate	Haloperidol Decanoate	15	suppressed
Methimazole	Methimazole	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Valproic Acid	Valproic Acid	15	suppressed
Anastrozole	Anastrozole	14	suppressed
Clonidine	Clonidine	14	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	14	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Atenolol	Atenolol	13	suppressed
Colchicine	Colchicine	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Sertraline Hcl	Sertraline Hcl	13	suppressed
Captopril	Captopril	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Potassium Chloride	Potassium Chloride	12	suppressed
Pravastatin Sodium	Pravastatin Sodium	12	suppressed
Prednisone	Prednisone	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Descovy	Emtricitabine/Tenofov Alafenam	11	suppressed
Lumigan	Bimatoprost	11	suppressed
Naproxen	Naproxen	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Santyl	Collagenase Clostridium Hist.	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error